# FDA Inspection 1259522 - Biotech, Inc. - January 30, 2025

Source: https://www.keypedia.com/records/fda_inspections/biotech-inc/26c61a63-6ed6-4bfc-a8af-b27d1374cc6f
Source feed: FDA_Inspections

> FDA Inspection 1259522 for Biotech, Inc. on January 30, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1259522
- Company Name: Biotech, Inc.
- Inspection Date: 2025-01-30
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1289106 - 2025-07-24](https://www.keypedia.com/records/fda_inspections/biotech-inc/8504c182-bde0-47f6-af59-0b1e41ca7103)
- [FDA Inspection 1272902 - 2025-05-20](https://www.keypedia.com/records/fda_inspections/biotech-inc/241e14f6-4c04-4c0e-902c-a8dcb899b2d1)
- [FDA Inspection 1048413 - 2018-02-28](https://www.keypedia.com/records/fda_inspections/biotech-inc/b7827d11-d084-4359-b739-405f2cf54cbe)
- [FDA Inspection 1048413 - 2018-02-28](https://www.keypedia.com/records/fda_inspections/biotech-inc/e577be2d-bee7-4201-a43d-28e21e4f9775)

Company: https://www.keypedia.com/companies/biotech-inc/75fad230-3a3a-490f-8843-7530908f5366

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d